Primary central nervous system lymphoma: Treatment with chemotherapy and radiotherapy

European Journal of Cancer

Volumn 31, Issue 12, 1995, Pages 2003-2007

  Sarazin, M ^a   Ameri, A ^a   Monjour, A ^b   Nibio, A ^a   Poisson, M ^a   Delattre, J Y ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Pasteur Hospital   (France)

Author keywords

chemotherapy; primary central nervous system lymphoma

Indexed keywords

FOLINIC ACID; METHOTREXATE; ONDANSETRON; PREDNISONE; PROCARBAZINE; THIOTEPA;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOENCEPHALOPATHY; LEUKOPENIA; LYMPHOMA; MALE; NAUSEA; PRIORITY JOURNAL; SEPSIS; THROMBOCYTOPENIA; THROMBOSIS; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029608867     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00345-2     Document Type: Article

References (28)

1. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy
2. Primary malignant lymphomas of the central nervous system in man
3. Increasing incidence of primary brain lymphoma in the U.S
4. Radiation therapy in the management of primary malignant lymphoma of the brain
5. Primary non Hodgkin lymphoma of the central nervous system: results of radiotherapy
6. Primary central nervous system lymphoma as a second malignancy
7. Combined modality therapy for primary CNS lymphoma
8. Adjuvant chemotherapy for primary lymphoma of the central nervous system
9. Developments in the diagnosis and treatment of primary CNS lymphoma
10. Successful treatment of recurrent primary central nervous system lymphoma with high dose methotrexate
11. High-dose methrotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases
12. Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3h intravenous infusion in children with non-Hodgkin's lymphoma
13. Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system
14. Primary central nervous system lymphoma
15. High dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin's lymphomas including CNS involvement
16. Phase II evaluation of thiothepa for treatment of central nervous system tumors
17. Treatment of neoplastic meningitis with intraventricular thiothepa and methotrexate
18. Chemoradiation in brain tumors. Adverse effects
19. Primary central nervous system lymphoma
20. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiation therapy oncology group
21. Primary malignant lymphomas of the central nervous system
22. The clinical spectrum of ocular lymphoma
23. Combined malignant lymphoma of the eye and CNS
24. Leukoencephalopathy following high dose methotrexate chemotherapy with leucovorin rescue
25. Neurologic sequelae of methotrexate and ionising radiation. A new classification
26. Concentration time methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms
27. Effect of irradiation on the pharmacokinetics of methotrexate in rats. Alteration of the blood brain barrier
28. Diagnosis factors in the diagnosis and treatment of primary central nervoussystem lymphoma